Search Results
Jun 22, 2026, 08:00 ET TrueLab Biopharmaceutical Announces License Agreement with Bionyra Pharma for Two Next-Generation Monoclonal and Bispecific Antibodies for Immune-Mediated Inflammatory Diseases Valued up to $985 Million
high-value therapeutic candidates and translate scientific innovation into globally competitive clinical assets.About TL-001 (BYN-002)TL-001 (also known as BYN-002) is an extended half-life, humanized IgG1 monoclonal antibody targeting human tumor necrosis factor-like cytokine 1A (TL1A). It
More news about: TrueLab Biopharmaceutical Co., Ltd.
Jun 22, 2026, 08:00 ET TrueLab Biopharmaceutical Announces License Agreement with Bionyra Pharma for Two Next-Generation Monoclonal and Bispecific Antibodies for Immune-Mediated Inflammatory Diseases Valued up to $985 Million
high-value therapeutic candidates and translate scientific innovation into globally competitive clinical assets.About TL-001 (BYN-002)TL-001 (also known as BYN-002) is an extended half-life, humanized IgG1 monoclonal antibody targeting human tumor necrosis factor-like cytokine 1A (TL1A). It
More news about: TrueLab Biopharmaceutical Co., Ltd.
Jun 22, 2026, 08:00 ET TrueLab Biopharmaceutical gibt Lizenzvereinbarung mit Bionyra Pharma über zwei monoklonale und bispezifische Antikörper der nächsten Generation zur Behandlung immunvermittelter Entzündungskrankheiten im Wert von bis zu 985 Millionen US-Dollar bekannt
setzt wissenschaftliche Innovationen in weltweit wettbewerbsfähige klinische Ressourcen um.Informationen zu TL-001 (BYN-002)TL-001 (auch bekannt als BYN-002) ist ein humanisierter monoklonaler IgG1-Antikörper mit verlängerter Halbwertszeit, der gegen das humane Tumornekrosefaktor-ähnliche
More news about: TrueLab Biopharmaceutical Co., Ltd.
Jun 22, 2026, 08:00 ET TrueLab Biopharmaceutical anuncia un acuerdo de licencia con Bionyra Pharma
valor y transformando la innovación científica en activos clínicos competitivos a nivel mundial.Acerca de TL-001 (BYN-002)TL-001 (también conocido como BYN-002) es un anticuerpo monoclonal IgG1 humanizado de vida media prolongada dirigido a la citocina 1A similar al factor de necrosis
More news about: TrueLab Biopharmaceutical Co., Ltd.
Jun 22, 2026, 08:00 ET TrueLab Biopharmaceutical annonce la signature d'un accord de licence avec Bionyra Pharma pour deux anticorps monoclonaux et bispécifiques de nouvelle génération destinés au traitement des maladies inflammatoires à médiation immunitaire, d'une valeur pouvant atteindre 985 millions de dollars
transforme l'innovation scientifique en actifs cliniques compétitifs à l'échelle mondiale.À propos du TL-001 (BYN-002)Le TL-001 (également connu sous le nom de BYN-002) est un anticorps monoclonal IgG1 humanisé à demi-vie prolongée ciblant la cytokine 1A de type facteur de nécrose tumorale
More news about: TrueLab Biopharmaceutical Co., Ltd.
Jun 08, 2026, 08:00 ET BLACKYAK Hosts "Himalayan Climate Charter 2026: Namche Summit" to Advance Global Climate Action
responsibility, grounded in the belief that nature is a precious legacy that must be preserved for future generations.About BYN BLACKYAK GroupFounded in 1973, BYN BLACKYAK Group is a global outdoor and lifestyle brand group inspired by the spirit of the Himalayas. Through its flagship brand
More news about: BLACKYAK
Jun 08, 2026, 03:00 ET BLACKYAK richtet den „Himalayan Climate Charter 2026: Namche Summit" aus, um globale Klimaschutzmaßnahmen zu fördern
Überzeugung beruhen, dass die Natur ein wertvolles Erbe ist, das für zukünftige Generationen bewahrt werden muss.Über die BYN BLACKYAK GroupDie 1973 gegründete BYN BLACKYAK Group ist eine globale Outdoor- und Lifestyle-Markenfamilie, inspiriert vom Geist des Himalaya. Mit ihrer Hauptmarke
More news about: BLACKYAK
Jun 07, 2026, 20:00 ET BLACKYAK舉辦「2026喜馬拉雅氣候憲章：南池峰會」，推動全球氣候行動
在推廣負責任戶外文化與倡導成熟登山文化方面的貢獻。此外，報告亦介紹了公司透過全球研發能力推動高效能技術創新、基於資源循環理念開發永續產品，以及建立涵蓋產品生產至廢棄全生命週期的循環經濟模式等努力，以創造更完整的環境價值。透過本報告，BLACKYAK傳達其品牌理念與責任意識：自然是必須為下一代妥善守護的珍貴遺產。關於 BYN BLACKYAK GroupBYN BLACKYAK Group成立於1973年，是一家受喜馬拉雅精神啟發的全球戶外與生活風格品牌集團。集團旗下旗艦品牌BLACKYAK及相關業務板塊，專注研發高效能戶外服飾、鞋履與裝備，產品專為應對全球最嚴苛環境需求而設計。秉持對創新、永續發展與負責任探索的堅定承諾，BYN
More news about: BLACKYAK
May 12, 2026, 09:05 ET The Yukon's Capital Cycle Has Turned -- and This 18-Project Junior Is Quietly Building the Next District-Scale Story
coarse scheelite — a tungsten-bearing mineral — adding a critical-metals dimension to the asset [10].Banyan Gold Corp. (TSXV: BYN) (OTCQB: BYAGF) is advancing the AurMac Project in the Tombstone Gold Belt, 40 kilometres from Mayo, Yukon, transected by the territory's main highway.
More news about: Equity Insider
Mar 02, 2026, 09:15 ET Gold Demand Just Broke a Record - Supply Can't Keep Up
production spectrum include Golden Goose Resources (CSE: GGR) (OTCQB: GGRFF), Omai Gold Mines (TSXV: OMG), Banyan Gold (TSXV: BYN), i-80 Gold (TSX: IAU), and Allied Gold (TSX: AAUC).
More news about: Equity Insider
Dec 15, 2025, 13:15 ET WENC "The New Power 1220" to Host Community Open House & Celebrity Meet-and-Greet on Saturday, December 20 in Whiteville
Stars Concert Tour (autographs available) - James Fortune, Paul Porter, Miz Tiffany, Kim Person, Calvin Norton, Earl Bynum, The Dynamic Abraham Brothers, Asaun BynMedia outlets are welcome to attend for interviews, photos, and community soundbites. Community organizations interested in partnering with WENC
More news about: WENC